Literature DB >> 10460644

Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen's disease).

S R Brown1, P Skinner, J Tidy, J H Smith, F Sharp, K B Hosie.   

Abstract

BACKGROUND: High-grade anal intraepithelial neoplasia (Bowen's disease) may predispose to anal carcinoma. Treatment options include surgical resection but effectiveness remains uncertain. This paper reports long-term follow-up of patients with high-grade anal intraepithelial neoplasia treated by surgical resection.
METHODS: Between 1989 and 1996, 46 patients were identified with high-grade anal intraepithelial neoplasia. Thirty-four underwent local excision of all macroscopically abnormal disease and the resulting defect was left open, closed primarily or skin grafted. Regular follow-up subsequently included anoscopy and biopsy of any suspicious lesions.
RESULTS: Median follow-up was 41 (range 12-104) months. Total excision was difficult; 19 patients had histological evidence of incomplete excision at the time of initial resection. Some 12 of 19 had histo-logically proven recurrent high-grade intraepithelial neoplasia within 1 year. Even with microscopically complete excision two of 15 patients subsequently developed recurrent high-grade intraepithelial neoplasia at 6 and 32 months after operation. No patient developed carcinoma but five had complica-tions of anal stenosis or faecal incontinence.
CONCLUSION: Although no definite recommendations can be made for the treatment of high-grade anal intraepithelial neoplasia, these results illustrate some potential drawbacks of surgical excision with a high potential for incomplete excision and persistent disease, even after complete excision in some patients, and a high morbidity rate.

Entities:  

Mesh:

Year:  1999        PMID: 10460644     DOI: 10.1046/j.1365-2168.1999.01184.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

Review 1.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

2.  Management of anal squamous intraepithelial lesions.

Authors:  Carlos E Pineda; Mark L Welton
Journal:  Clin Colon Rectal Surg       Date:  2009-05

Review 3.  Anal squamous cell carcinoma: an evolution in disease and management.

Authors:  Marc C Osborne; Justin Maykel; Eric K Johnson; Scott R Steele
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Anal intraepithelial neoplasia in HIV positive people.

Authors:  F Martin; M Bower
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

5.  Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR).

Authors:  G A Binda; G Gagliardi; I Dal Conte; M Verra; P Cassoni; E Cavazzoni; E Stocco; S Delmonte; P De Nardi; L Sticchi; M Mistrangelo
Journal:  Tech Coloproctol       Date:  2019-06-26       Impact factor: 3.781

6.  High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients.

Authors:  Carlos E Pineda; J Michael Berry; Naomi Jay; Joel M Palefsky; Mark L Welton
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

7.  Anal screening cytology.

Authors:  Gladwyn Leiman
Journal:  Cytojournal       Date:  2005-02-16       Impact factor: 2.091

8.  Endoscopic submucosal dissection for anal intraepithelial neoplasia.

Authors:  Junichi Miyazaki; Noriya Uedo; Zhao Liang Li; Shohei Matsuo
Journal:  Ann Gastroenterol       Date:  2016-05-11

9.  Current treatment options for management of anal intraepithelial neoplasia.

Authors:  Stephen E Weis
Journal:  Onco Targets Ther       Date:  2013-06-10       Impact factor: 4.147

10.  Acantholytic Variant of Bowen's Disease with Micro-invasive Squamous Cell Carcinoma: A Case Report of a Unique Variant.

Authors:  Kanthilatha Pai; Shricharith Shetty; J Padmapriya; Sathish Pai; Lakshmi Rao
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.